Identification and characterization of two novel germline RET variants associated with medullary thyroid carcinoma

Endocrine
A L SilvaM J Bugalho

Abstract

Activating germline mutations in the RET proto-oncogene are responsible for about 98 % of the familial forms of medullary thyroid carcinoma (MTC), which represent 25 % of all MTC cases. The search for germline mutations in this gene is important for the recognition of hereditary forms of MTC and further identification of at-risk relatives who may benefit from early clinical intervention. Genotype-phenotype correlations are well established for most disease-causing RET mutations, allowing risk stratification. The association of a new RET variant with the MTC phenotype and familial predisposition requires the assessment of its functional and clinical significance. The aim of this study was to evaluate the oncogenic potential of two newly identified RET germline variants associated with late-onset MTC. In vitro functional assays were designed to address the transforming potential of novel RET variants, through their expression in non-transformed cells, and comparing their effect with wild-type RET. The new variants were identified in codons 515 (p.C515W) and 636 (p.T636M) located, respectively, in exons 8 and 11, thus resulting in amino acid substitutions in the extracellular region of the tyrosine kinase receptor RET. Through fun...Continue Reading

References

Mar 12, 2002·The Journal of Biological Chemistry·Toshifumi FukudaMasahide Takahashi
Jun 29, 2005·Cytokine & Growth Factor Reviews·Elena ArighiHannu Sariola
Oct 12, 2005·Proceedings of the National Academy of Sciences of the United States of America·Thomas Ho-Yin LeungIrene Oi-Lin Ng
Nov 30, 2006·Journal of Surgical Oncology·Ronald A DeLellis
Jul 18, 2008·Thyroid : Official Journal of the American Thyroid Association·Francesca FazioliAugusto Taccaliti
Apr 23, 2009·Journal of Molecular Endocrinology·Aniello CerratoMassimo Santoro
Jan 28, 2010·European Journal of Endocrinology·Marina MuzzaLaura Fugazzola
Oct 12, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John E Phay, Manisha H Shah
Feb 5, 2013·Cold Spring Harbor Perspectives in Biology·Carlos F Ibáñez
Apr 9, 2013·Experimental Cell Research·Wen-Hsin HsuLi-Ru You
Jan 23, 2014·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Isabel HuguetAshley B Grossman
Feb 25, 2014·Nature Reviews. Cancer·Lois M Mulligan

❮ Previous
Next ❯

Citations

Nov 18, 2018·Nature Communications·Bhavna S ParatalaKim M Hirshfield

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.